Simple anatomic metrics such as %DS assume that coronary physiology depends only on that single parameter. More (Circ Cardiovasc Imaging. 2013;6:817-832.)
A pproximately 40 years ago, we began to link coronary anatomy to its physiology. In those early experiments, percent diameter stenosis (%DS) provided a simple yet appropriate metric of anatomy because every lesion was created externally to an otherwise normal coronary artery by an adjustable, focal occluder of uniform length. 1 Since that time, a wide array of anatomic techniques has been proposed to predict physiological severity. But what insights have we gained from this work during the past 4 decades? Will we ever be able to predict physiology completely from anatomy? Or, like an isotope undergoing radioactive decay, must we content ourselves with a statistical and mechanistic understanding but without individual application?
This review surveys the long and ongoing journey to predict physiology from anatomy in the coronary circulation. We begin with several general principles that apply to all techniques. Next we detail the 2 broad methods used for physiology prediction: single parameters (like %DS) and computational modeling. For each method, we explicitly provide the underlying assumptions. We compare the expected behavior between anatomy and physiology with representative experimental data from the literature. Although the concepts apply equally to animal models, we have chosen to present only results from humans to maximize clinical relevance.
The data reveal a clear and simple message: Coronary anatomy alone will never be sufficient to predict physiological behavior at the level of a single patient. However, anatomic parameters and models will continue to provide a useful framework for understanding physiological behavior in general.
General Principles
An inaccurate prediction can result from only 2 general reasons. First, input parameters may contain uncertainty. The butterfly effect from weather forecasting, 2 whereby small changes in initial conditions can produce large downstream effects ("Does the flap of a butterfly's wings in Brazil set off a tornado in Texas?," provides a classic example). Second, the predictive model may contain inaccurate assumptions. For example, Ohm's empirical law relating current to potential difference in electric circuits does not apply to certain devices such as a diode or thermistor. Typically, our predictive assumptions reflect group behavior well but do not account for biological variability. Both of these general principles can be seen in using coronary anatomy to predict physiology.
Uncertainty in Input Parameters
The Poiseuille equation relates pressure drop in a rigid tube to the fourth power of the vessel radius under certain conditions (a newtonian fluid during steady, fully developed, laminar flow). Therefore, a small uncertainty in the angiogram becomes magnified into a large uncertainty in model output.
For example, assume a 4.4-mm reference diameter of the left main coronary artery with a 50% diameter stenosis such that the minimum lumen diameter (MLD) equals 4.4 mm×0.50=2.2 mm, equivalent to a radius of 1.1 mm. Current invasive angiographic technology provides a resolution of ≈0.2 mm. 3 Using standard error propagation techniques, the relative error in the pressure gradient equals 4×0.2/1.1=73%. For intravascular ultrasound (IVUS), with an improved anatomic resolution of ≈0.1 mm, 4 the relative error decreases to 4×0.1/1.1=36%. Optical coherence tomography (OCT) offers an anatomic resolution of ≈0.02 mm, 4 reducing the relative error in the pressure gradient further to 4×0.02/1.1=7%. However, computed tomography angiography (CTA) provides a resolution of ≈0.6 mm. 5 Using CTA imaging would increase the relative error to 4×0.6/1.1=218%.
This simplistic example demonstrates how imaging resolution produces uncertainty in anatomic parameters even in the largest portion of the coronary tree with a single stenosis. The Poiseuille relationship does not completely capture the full physiology of the coronary circulation but serves here to offer a straightforward conceptual example using 1-dimensional uncertainty. The addition of diffuse disease alters the reference segment, which itself also has anatomic uncertainty because of imaging. More complex models that incorporate >1 parameter (eg, both vessel radius and lesion length) compound the relative uncertainty in each value. complex models such as stenosis flow reserve (SFR) or predicted fractional flow reserve (FFR) from computed tomographic angiography (FFR CT ) use many anatomic parameters but assume various physiological relationships among them. Both types of assumptions often reflect typical group behavior but may not necessarily apply to every patient. Stated another way, the assumptions can be accurate (little or no bias on average) but imprecise (large scatter among patients). Improving precision beyond a certain point seems impossible using anatomic variables alone.
Sources of Scatter
Three important sources of scatter must be kept distinct: measurement uncertainty, test-retest repeatability in the same patient, and group differences resulting from biological variability. Both anatomic and physiological variables contain measurement uncertainty. As discussed above, anatomic resolution provides a fundamental lower limit on the certainty of any geometric measurement. Typical resolutions equal ≈0.02 mm for OCT, 4 0.1 mm for IVUS, 4 0.2 mm for conventional angiography, 3 and 0.6 mm for CTA angiography. 5 The precision and fidelity of invasive pressure and Doppler velocity signals provide an analogous uncertainty for physiological measurements.
Any measurement can change for many reasons when repeated a short time later, so-called test-retest repeatability. For example, anatomic measurements may change over just a few minutes because of different camera positions during angiography, altered vasomotor tone including spasm, selected portion of the cardiac cycle especially with myocardial bridging, or a change in contrast media opacification. Similarly, physiological measurements can also change for many reasons when repeated a short time later (decreased aortic driving pressure during systemic vasodilator infusion, compensatory tachycardia, sympathetic tone resulting from vasodilator side effects, sensor movement or drift, time-varying response to vasodilator infusion). Table 1 reviews the existing literature on the repeatability of anatomic and physiological measurements. Measurement uncertainty and imperfect repeatability of both anatomic and physiological parameters reduce the observed correlation between them, as is well known statistically. 38 Therefore, we should not expect correlation coefficients near 1 even for extremely predictive anatomic parameters or models.
Finally, biological variability among subjects would produce scatter even without measurement uncertainty and with perfect test repeatability. Short-term biological variability in the same stable subject, in the order of minutes, becomes incorporated into test-retest repeatability. Such near-term variability carries no clinical importance but can be difficult to distinguish from imperfect test repeatability. However, biological variability among subjects refers to population differences in the response to essentially identical circumstances. For example, an identical stenosis in 2 different patients can produce 2 distinct hemodynamic consequences because of parameters such as rest flow, myocardial bed size, blood pressure and heart rate, achievable hyperemic flow capacity, and interactions between stenoses and coronary branches.
Single Anatomic Parameters
The most discussed single anatomic parameters include %DS, MLD, and minimum lumen area (MLA). Each can be measured using angiographic techniques (invasive or noninvasive), especially quantitative coronary angiography (QCA) and CTA, or intravascular imaging, namely IVUS or OCT. We have chosen to focus exclusively in this review on %DS and MLA because only these parameters and MLD receive explicit mention in the current American guidelines for mechanical revascularization 39 :
1. "for revascularization decisions and recommendations in this section, a "significant" stenosis has been defined as ≥70% diameter narrowing (≥50% for left main CAD [coronary artery disease]" 2. "For left main coronary artery stenoses, a minimal lumen diameter of <2.8 mm or a minimal lumen area of <6 mm 2 suggests a physiologically significant le-sion… a minimal lumen area >7.5 mm 2 suggests that revascularization may be safely deferred … a minimal lumen area between 6 and 7.5 mm 2 requires further physiological assessment" 3. "for non-left main stenoses, minimal lumen diameter >2.0 mm and minimal lumen area >4.0 mm 2 correlate with low event rates."
Many other single anatomic parameters have been studied such as percent area stenosis, lesion length, and plaque burden but are not detailed further here because they do not appear in the guidelines.
Similarly, FFR represents the most discussed physiological parameter and the only one that receives explicit mention in the current American guidelines for mechanical revascularization 39 :
1. "for recommendations about revascularization … coronary stenoses with FFR ≤0.80 can also be considered to be significant and" 2. "FFR is reasonable to assess angiographic intermediate coronary lesions (50% to 70% diameter stenosis) and can be useful for guiding revascularization decisions in patients with [stable ischemic heart disease]."
Many other physiological parameters such as coronary flow reserve (CFR) and hyperemic stenosis resistance have been studied 40 but are not detailed further because they do not appear in the current guidelines. Figure 1A depicts the expected relationship between %DS and FFR using the SFR model and typical reference lumen dimensions. 41 Figure 1B displays >1000 observations in humans using %DS by QCA. 41 In general, FFR falls in a nonlinear, roll-off fashion as %DS increases, with a modest effect of reference vessel dimensions. Figure 1B demonstrates even wider scatter than in Figure 1A , which focuses on only 1 parameter that affects FFR and ignores biological variability. The wide scatter from Figure 1B can be observed in the published studies summarized in Table 2 , showing optimal cutoffs ranging from 50%DS to 70%DS compared with FFR. Table 1 On the basis of wide scatter and large confidence intervals between %DS and FFR, the concept of a single critical %DS cutoff-suggested 40 years ago by the senior author of this review 1 : "88 to 93 percent constriction … defined here as critical coronary stenosis"-now has been shown to be too simplistic and too imprecise for individual human application. Figure 2A depicts the expected relationship between MLA and FFR using the SFR model and typical reference vessel dimensions. 55 Figure 2B displays >350 observations in humans using MLA measured by IVUS. 55 In general, FFR increases in a curvilinear fashion as MLA increases although its exact shape Gonzalo depends on the absolute size of the reference vessel lumen. Figure 2B demonstrates wide scatter, as reflected in the published studies summarized in Table 3 , showing optimal cutoffs ranging from 2.4 to 3.5 mm 2 compared with FFR. Table  1 shows that MLA has a 95% confidence interval between 0.6 and 1.2 mm 2 because of test repeatability. MLD relates closely to MLA through the formula for the area of a circle, namely MLA=(π/4)×MLD 2 . American revascularization guidelines39 suggest <2.8-mm MLD for left main lesions equates to a <6.2-mm2 MLA; the suggested >2.0 mm MLD for non-left main lesions, which equates to a >3.1-mm 2 MLA. These values are close, but not exactly equal, to the suggested cutoffs of <6 and >4.0 mm 2 , thereby highlighting both the eccentric nature of coronary atherosclerosis and some degree of anatomic uncertainty in the thresholds. Table 1 shows that MLD has a 95% confidence interval of approximately ±0.2 to 0.6 mm because of test repeatability.
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Computational Modeling
Major, existing, clinical models include SFR and FFR from CT (FFR CT ). After discussing SFR and FFR CT in detail, we briefly discuss 3 other computational models that have been used in a small number of patients. Other published simulations of the coronary vasculature 65 have not yet been studied in humans.
Stenosis Flow Reserve
SFR was proposed in 1986 66 with the development and spread of QCA, but before the significant introduction of intravascular sensors for Doppler velocity. 67 SFR originally used a model of a single stenosis connected to a single myocardial bed, 66 although more recent updates have expanded to multiple epicardial segments and myocardial beds. [68] [69] [70] Note that SFR was originally called computed or predicted CFR, and the term stenosis flow reserve did not appear until a 1990 study, 71 whereas subsequent extensions have 68 or have not 69, 70 used the term SFR. Building on seminal animal work from the 1970s, SFR proposed standardized conditions to isolate and test the hemodynamic consequences of a stenosis. SFR makes these following main physiological assumptions:
1. A quadratic function of flow completely describes pressure drop across a stenosis; its coefficients depend on the lesion length, reference lumen area (derived from the distal vessel unless at a bifurcation), MLA of lesion (areas derived using an ellipsoid model), and blood properties. Several potential limitations to these assumptions exist:
1. A quadratic function does not describe every stenosis because of changing stenosis geometry, 72 Starling resistor effects, 73 or myocardial steal attributable to collaterals 74 or branch steal. 68 
At low pressures, myocardial bed physiology may not
remain linear because of decompression 75 although the issue remains controversial. 3. Systemic pressure typically decreases with vasodilation 76 instead of remaining fixed and obviously varies among individuals, as does venous pressure. 4. Rest flow varies widely among individuals, showing a large spread around the group average. 77 
Normal, maximal CFR varies widely among individuals,
showing a large spread around the group average. 78 6. Flow is typically much greater during diastole than systole although a severe stenosis can either blunt or even reverse this relationship. 72 7. Blood properties such as density and viscosity can be abnormal in the setting of polycythemia and other disorders. Figure 3A depicts the expected theoretical relationship between FFR and SFR, namely a straight line but with a slope of ≈1/5 resulting from the normal CFR=5 without a stenosis. Figure 3B displays experimental data from >100 observations in humans. 45 Table 4 summarizes the results from human studies comparing SFR with invasive physiology.
Philips Electronics (Best, The Netherlands) digital cardiac imaging system offered a QCA software package around the late 1980s and early 1990s called automated coronary analysis that incorporated the SFR algorithm as a routine feature, providing an almost immediate computational result. However, sufficient development of high-quality intravascular sensors 67, 83 and pharmacological agents for reliable, sustained hyperemia 84, 85 had occurred by the early 1990s. Therefore, computed SFR was displaced eventually by direct measurements of CFR or FFR in patients. Although the original SFR algorithm is essentially no longer available commercially, the modern SFR algorithm with multiple vessels and beds incorporating pulsatile flow has been described fully [68] [69] [70] and is available as free source code from the authors on request.
FFR From CT
Computational modeling to predict FFR from CT imaging of anatomy (FFR CT ) was proposed in 2010 86 Several potential limitations to these assumptions exist:
1. FFR derives from pure vasodilation, 87 not from exercise.
CFR varies widely among individuals, showing a large
spread around the group average. 88 
Cardiac output increases greatly with exercise 89 but does
not change or increases only slightly with vasodilation, 90, 91 whereas coronary blood flow increases in both cases. 4. Systemic pressure typically decreases with vasodilation, whereas heart rate rarely triples with adenosine. 76 
Minimum myocardial resistance shows a large spread
around the group average. 92 6. Flow distribution among coronary artery branches depends on distal mass but again with a wide spread around the group average. 93 
Blood properties such as density and viscosity can be
abnormal in the setting of polycythemia and other disorders. Figure 4A depicts the expected theoretical relationship between FFR and FFR CT , namely a straight line. Figure 4B displays the scatterplot from >150 observations in the DISCOVER-FLOW study. 94 Table 5 summarizes the results from the 2 completed human studies comparing FFR CT with invasive FFR. Although a scatterplot and Bland-Altman analysis from DeFACTO were not part of its original publication, 95 they will appear in an upcoming manuscript (James K. Min, personal communication).
Two existing studies (DISCOVER-FLOW and DeFACTO) sought to determine the diagnostic performance of FFR CT , using invasive FFR as the reference standard. 94, 95 Overall, DeFACTO failed to meet its prespecified primary end point of diagnostic accuracy. Several ongoing trials continue to study the diagnostic performance of FFR CT : †Bias and limits of agreement computed after manual extraction of data from its Figure 3 . ‡Bias and limits of agreement computed using raw data provided in its Table 1 . §Bias and limits of agreement computed using raw data provided in its Table 2 . ‖Cutoff, area, and accuracy computed after manual extraction of data from its Figure 3 (bottom) . ¶Cutoff, area, and accuracy computed using raw data provided in its Table 1 . Currently, the FFR CT algorithm remains proprietary. HeartFlow (Redwood City, CA) owns the technology, although at this time it is not commercially available in the United States. Because of processing and computational requirements and a presumed desire not to disclose the algorithm, individual users do not receive the software but instead upload CTA images to a Web site owned by the company. The user can view a report after centralized processing (≈5-6 hours per case). Table 6 summarizes the results from 3 single-center publications of other computational models that have each been tested in ≈20 patients. By contrast, SFR and FFR CT have several publications from multiple groups and have each been tested in >200 patients.
Stable patients, started in
Other Models
In 2001, 3D-IVUS was suggested to predict FFR. 96 It applies one of the main equations that underlie SFR but uses anatomy from an IVUS pullback. Specifically, 3D-IVUS makes at least the following physiological assumptions: The fixed hyperemic coronary blood flow velocity of 50 cm/s agreed well with the average measured value of 49.9 cm/s using an invasive Doppler wire. However, its observed variation among patients, SD ±16.2 cm/s, again underscores biological variability. No commercial implementation of 3D-IVUS exists, and the original publication did not list processing times per case. Notably, 3D-IVUS requires instrumentation of the coronary arteries of similar risk and complexity to measuring FFR directly.
Virtual FFR predicts FFR from invasive, rotational coronary angiography and was published in early 2013. 97 Similar to FFR CT , virtual FFR applies the Navier-Stokes equations in the epicardial circulation but also uses a Windkessel model for the distal myocardial bed. Specifically, virtual FFR makes at least the following physiological assumptions:
1. Universal proximal pressure waveform that reflects group average. 2. Generic microvascular resistance and compliance for the distal myocardial bed. *Statistics computed from raw data given in its Table 2 .
†Statistics computed from raw data given in its Figure 3 .
‡Statistics computed from raw data given in its Figure 6 .
Clearly, these assumptions hold on average but will not apply to every individual patient. Indeed, its authors admit that "we averaged the resistance and compliance values to produce a generic value applicable to the whole cohort. The accuracy of [virtual PCI] with these averaged boundary conditions would be lower than that obtained using individually tuned parameters." 97 No commercial implementation of virtual percutaneous coronary intervention (PCI) exists at this time. Current processing times last ≈24 hours per case. In addition, virtual FFR requires an invasive angiogram like SFR but in contrast to FFR CT .
The vascular resistance ratio (VRR) predicts FFR from OCT imaging and was published in early 2013. 98 VRR applies a lumped parameter model similar to SFR but uses anatomy from an OCT pullback. Specifically, VRR makes at least the following physiological assumptions: As with every other computational model, these assumptions hold on average but will not apply to every individual patient. The authors of VRR write that "substantial scatter is evident between model-based predictions of FFR and measured FFR readings. The parameters of the VRR model are based on population averages that account only partially for physiological variations among patients … [VRR] cannot account for individual variations in hyperaemic response and myocardium mass." 98 No commercial implementation of VRR exists at this time, although a patent application was submitted in early 2011. Modeling times took <1 second per case after anatomic segmentation, the additional time for which was not reported. In addition, VRR requires instrumentation of the coronary arteries of similar risk and complexity to measuring FFR directly.
Summary statistics in Table 6 for 3D-IVUS, virtual FFR, and VRR show reasonable average agreement yet wide scatter unsuitable for individual application, just as with SFR and FFR CT in Tables 4 and 5 , albeit limited by the much smaller sample sizes. Comparing the predictive performance among SFR, FFR CT , IVUS-derived FFR, virtual FFR, and VRR (contrast Tables 4-6 and Figures 3 and 4) demonstrates similar diagnostic ability despite vast differences in model complexity and computing requirements.
Perspective
The preceding survey of the literature makes clear that both single anatomic parameters and computational models perform reasonably well on average but demonstrate wide scatter. Figure 5 emphasizes that even when image resolution improves by ≈6-fold (between IVUS and CTA), it only serves to unmask the underlying biological variability. FFR CT seems dominated by lower image resolution from CTA ( Figure 5A ); higher resolution MLD using IVUS seems dominated by biological variability ( Figure 5B ). Therefore, predicting physiology from anatomy is accurate (small bias on average) but imprecise (large bounds of uncertainty because of scatter). Such imprecision precludes application to make a definitive diagnosis for individual patients, particularly when high-quality physiological tests such as quantitative imaging (like positron emission tomography) and invasive FFR exist.
Outcome Studies
Clinical outcome studies offer the deciding argument for measuring coronary physiology instead of inferring it from the epicardial anatomy. Large randomized trials looking at hard outcomes have used either anatomic or physiological entry criteria. The comparison in Table 7 makes clear that mechanical revascularization trials using anatomy (published in the past 10 years to examine modern medical therapy) have not improved outcomes, in contrast to physiology-based revascularization trials. Figure 6 compares the survival curves for the COURAGE (anatomic) and FAME (physiology) trials. "Coronary flow trumps coronary anatomy" for outcomes. 109
Biological Variability Versus Standard Conditions
Previously, the senior authors of this review have suggested that the standardized assumptions for SFR may be preferred: "arteriographic SFR may not equal the directly measured coronary flow reserve by flowmeter or Doppler-tip catheter in a given subject at a given time because the pressure and normal maximal flow for the patient at the time of direct flow measurements might not be the same as those assumed for the standardized arteriographic analysis. However, from another point of view, this apparent disadvantage of the arteriographic approach is also a benefit because arteriographic flow reserve allows comparison of complex lesions of different shapes in different patients without misleading effects on SFR because of differences in physiological conditions among the patients separate from stenosis geometry." 66 The QT interval on the ECG offers an analogy. Do we want to understand how a stenosis actually alters physiology in this specific patient (raw QT interval)? Or do we want to understand how a stenosis would alter physiology under standard conditions (corrected QT interval [QTc] at 60 bpm)? SFR offers the equivalent of a QTc for a coronary stenosis: uniform, physiological evaluation of its geometric effects alone. Just as QTc may or may not reflect the actual QT interval if the heart rate were to change to 60 bpm, 110 the SFR may or may not reflect the actual CFR. But both QTc and SFR facilitate comparison among patients by removing biological variability.
Recently, others have proposed to plan mechanical revascularization, such as PCI, using computational models. 111, 112 The above discussion makes clear that no model can predict the observed values with high precision to determine the necessity of intervention in an individual. At best we can instead study how various mechanical revascularization strategies might impact pressure and flow relative to whatever baseline assumptions were made. To continue the above analogy, virtual PCI may predict effects of PCI before doing it, similar to QTc predicting how QT might respond to a slower heart rate. However, both responses may unfold differently in real life. After the necessity of intervention is determined by direct physiological measurements, the anatomic data may aid in management without predicting an exact or actual physiological value by providing general mechanistic insights such as the method or details of intervention (PCI versus surgical bypass grafting), tandem lesions (likely treat one or both?), side branches (anticipate bifurcation strategy), heavy calcifications (consider aggressive pretreatment of the lesion), and diffuse disease (challenging for focal PCI).
Therefore, biological variability drives individualized diagnosis and necessity of intervention. However, standard conditions facilitate comparison among individuals or between contemplated anatomic modifications in the same individual.
Individual Prediction Versus Mechanistic Understanding
What is our goal in using coronary anatomy to predict physiology? Do we want to further our general understanding of coronary function? Or do we want to make a diagnosis or therapeutic decision in an individual patient? Currently, we understand well the general relationships between coronary anatomy and physiology. However, the wide scatter seen in all anatomic variables, including %DS, MLA, MLD, SFR, and FFR CT , does not allow accurate predictions of specific physiology values in individual patients. Both single anatomic parameters and especially computational models have advanced our mechanistic comprehension. For example, our own group has used expanded versions of the SFR model to study steal arising from the branching structure of the coronary tree 68 to understand the broad principles behind the discordance between FFR and CFR 69 and to explain the physiology behind the instantaneous wave-free ratio. 70 Similarly, the SFR model in the present article created the expected curves in Figures 1A, 2A , 3A, and 4A, demonstrating how anatomic uncertainty propagates into physiological uncertainty and matched by human measurements. In all cases, our model was not intended to predict individual values as a diagnostic application but rather to study interactions, physiological variables, and mechanisms.
Conclusions
Forty years of predicting coronary physiology from epicardial anatomy offers several clear lessons as surveyed above. First, we understand the general principles that relate the 2 domains. Second, a combination of imaging resolution, test-retest repeatability, and biological variability produces unacceptable scatter for all anatomic techniques when applied to individual patients. Third, physiology trumps anatomy for superior clinical outcomes. Fourth, anatomic prediction can be useful for advancing our mechanistic understanding.
The combined evidence implies that coronary anatomy alone will never be sufficient to predict specific physiological behavior at the level of a single patient. Therefore, further efforts should focus instead on measuring physiology itself, either noninvasively or invasively. As a corollary, the existing American guidelines on revascularization based on %DS, MLD, and MLA as detailed at the beginning 39 require fundamental revision. Specifically, anatomic imaging (IVUS, OCT, and CTA) should be performed rarely, if ever, when making a decision on the necessity of mechanical revascularization in stable patients but can be invaluable regarding its feasibility or procedural details. [113] [114] [115] Especially when instrumenting the coronary arteries, it makes little sense to perform IVUS or OCT instead of measuring FFR directly. ''Even the authors of a recent prospective IVUS study using FFR as the reference standard concluded that physicians should primarily use their clinical judgment and FFR because FFR is the most accurate tool to detect ischemia.'' 55 In conclusion, we can do no better than to bookend with a message from almost 40 years ago; ''although the coronary arteriogram does provide anatomic definition of coronary lesions, it offers little insight into their hemodynamic consequences.'' 1
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